Compare DHT & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DHT | TXG |
|---|---|---|
| Founded | 2005 | 2012 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.3B |
| IPO Year | 2005 | 2019 |
| Metric | DHT | TXG |
|---|---|---|
| Price | $18.63 | $22.68 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 15 |
| Target Price | $16.33 | ★ $17.18 |
| AVG Volume (30 Days) | ★ 5.2M | 2.0M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 5.41% | N/A |
| EPS Growth | N/A | ★ 76.97 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $245,893,000.00 |
| Revenue This Year | $8.85 | N/A |
| Revenue Next Year | N/A | $7.26 |
| P/E Ratio | $12.73 | ★ N/A |
| Revenue Growth | N/A | ★ 68.06 |
| 52 Week Low | $9.00 | $6.78 |
| 52 Week High | $20.55 | $23.56 |
| Indicator | DHT | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 58.69 | 62.98 |
| Support Level | $10.85 | $11.62 |
| Resistance Level | $20.55 | $23.43 |
| Average True Range (ATR) | 0.70 | 1.30 |
| MACD | -0.02 | 0.38 |
| Stochastic Oscillator | 96.91 | 95.04 |
DHT Holdings Inc is a crude oil tanker company. The company's primary business is operating a fleet of crude oil tankers, with a secondary activity of providing technical management services. Its fleet trades internationally and consists of VLCC crude oil tankers. The group generates revenues from time charter and spot market operations. It operates vessels through its subsidiary management companies in Monaco, Norway, Singapore, and India. The company generates the majority of its revenue from Voyage charter revenues.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).